CHA
AXSM icon

Carmichael Hill & Associates’s Axsome Therapeutics AXSM Stock Holding History

Carmichael Hill & Associates’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$9K – 790
2022
Q3 		$9K Hold
200
– – ﹤0.01% 580
2022
Q2 		$8K Hold
200
– – ﹤0.01% 590
2022
Q1 		$8K Buy
200
+100
+100% +$3.1K ﹤0.01% 625
2021
Q4 		$4K Hold
100
– – ﹤0.01% 717
2021
Q3 		$3K Sell
100
-200
-67% -$7.79K ﹤0.01% 723
2021
Q2 		$20K Buy
300
+50
+20% +$3K 0.01% 515
2021
Q1 		$14K Hold
250
– – 0.01% 541
2020
Q4 		$20K Hold
250
– – 0.01% 467
2020
Q3 		$18K Hold
250
– – 0.01% 441
2020
Q2 		$21K Sell
250
-250
-50% -$19.2K 0.02% 403
2020
Q1 		$29K Sell
500
-300
-38% -$24.4K 0.03% 329
2019
Q4 		$83K Buy
+800
New +$32.3K 0.06% 217

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return